SCHIRALDI, Chiara
 Distribuzione geografica
Continente #
EU - Europa 17.653
NA - Nord America 9.477
AS - Asia 7.007
SA - Sud America 1.064
Continente sconosciuto - Info sul continente non disponibili 573
AF - Africa 83
OC - Oceania 7
Totale 35.864
Nazione #
RU - Federazione Russa 11.395
US - Stati Uniti d'America 9.295
SG - Singapore 2.467
IE - Irlanda 1.786
CN - Cina 1.554
IT - Italia 1.378
HK - Hong Kong 1.036
VN - Vietnam 906
BR - Brasile 886
UA - Ucraina 726
GB - Regno Unito 655
DE - Germania 612
TR - Turchia 263
KR - Corea 232
FI - Finlandia 230
FR - Francia 193
SE - Svezia 191
IN - India 169
GR - Grecia 158
CA - Canada 89
AR - Argentina 71
BD - Bangladesh 71
JP - Giappone 69
NL - Olanda 62
BE - Belgio 56
ID - Indonesia 43
PK - Pakistan 40
AT - Austria 39
PL - Polonia 39
MX - Messico 37
ES - Italia 31
ZA - Sudafrica 27
EC - Ecuador 24
IQ - Iraq 23
CO - Colombia 22
CL - Cile 20
CZ - Repubblica Ceca 18
CH - Svizzera 16
LT - Lituania 15
UZ - Uzbekistan 15
PH - Filippine 12
IR - Iran 11
JM - Giamaica 11
KE - Kenya 11
PY - Paraguay 11
SA - Arabia Saudita 11
VE - Venezuela 11
MA - Marocco 10
AZ - Azerbaigian 9
CR - Costa Rica 8
PE - Perù 8
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
DZ - Algeria 7
EU - Europa 7
HU - Ungheria 7
NP - Nepal 7
PT - Portogallo 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
HN - Honduras 6
JO - Giordania 6
AM - Armenia 5
KG - Kirghizistan 5
AL - Albania 4
AU - Australia 4
BJ - Benin 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
LB - Libano 4
MY - Malesia 4
NI - Nicaragua 4
OM - Oman 4
RO - Romania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
BW - Botswana 3
CY - Cipro 3
EE - Estonia 3
GT - Guatemala 3
KZ - Kazakistan 3
MD - Moldavia 3
PS - Palestinian Territory 3
SV - El Salvador 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
DK - Danimarca 2
GE - Georgia 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
TO - Tonga 2
AD - Andorra 1
AG - Antigua e Barbuda 1
BN - Brunei Darussalam 1
Totale 35.270
Città #
Moscow 4.041
Dublin 1.783
San Jose 1.326
Singapore 1.149
Santa Clara 1.105
Jacksonville 1.100
Hong Kong 1.016
Chandler 974
Ashburn 472
Beijing 316
Council Bluffs 316
Ho Chi Minh City 280
Bremen 236
Princeton 230
Hanoi 216
Seoul 209
Ann Arbor 206
Naples 196
New York 188
Roxbury 188
Medford 174
Hefei 160
Caserta 149
Dallas 126
Wilmington 108
Los Angeles 102
Woodbridge 100
The Dalles 98
Bengaluru 88
São Paulo 77
Boardman 74
Cambridge 72
Da Nang 67
Napoli 66
Munich 65
San Mateo 60
Aversa 57
Rome 55
Brussels 51
Des Moines 51
Milan 44
Helsinki 41
Nanjing 40
Frankfurt am Main 38
Haiphong 38
Mountain View 35
Orem 35
Dong Ket 32
Memphis 30
Warsaw 29
Düsseldorf 28
Amsterdam 27
Tokyo 27
Atlanta 25
Phoenix 25
Rio de Janeiro 25
Shanghai 25
Jinan 24
Zhengzhou 24
Biên Hòa 23
Chicago 23
Falkenstein 23
Shenyang 23
Auburn Hills 22
London 22
Houston 21
Istanbul 21
Nuremberg 21
Paris 21
Volla 21
Brasília 20
Chennai 20
Guangzhou 20
Montreal 20
Norwalk 19
Vienna 19
Jakarta 18
Johannesburg 18
Lucca 17
Brooklyn 16
Campinas 16
Ottawa 16
Toronto 16
Changsha 15
Kochi 15
Manchester 15
Stockholm 15
Turku 15
Curitiba 14
Islamabad 14
San Francisco 14
Seattle 14
Thái Nguyên 14
Tianjin 14
Belo Horizonte 13
Brno 13
Hải Dương 13
Lanzhou 13
Mexico City 13
Salvador 13
Totale 18.652
Nome #
Derivati 3-eteroarilfenolici come nuovi potenti inibitori della 5-lipossigenasi 276
Antibodies against food antigens in patients with autistic spectrum disorders. 261
Biotechnological Chondroitin a Novel Glycosamminoglycan With Remarkable Biological Function on Human Primary Chondrocytes 223
Chimica e propedeutica Biochimica 221
Biophysical and biological characterization of a new line of hyaluronan-based dermal fillers: A scientific rationale to specific clinical indications 206
Evaluation of unsulfated biotechnological chondroitin in a knee osteoarthritis mouse model as a potential novel functional ingredient in nutraceuticals and pharmaceuticals 198
Acellular dermal matrix used in diabetic foot ulcers: Clinical outcomes supported by biochemical and histological analyses 198
Intestinal Dysbiosis and Yeast Isolation in stool of subjects with Autism Spectrum Disorders 190
Fighting for territories: time-lapse analysis of dental pulp and dental follicle stem cells in co-culture reveals specific migratory capabilities. 189
Optimization of growth of Levilactobacillus brevis SP 48 and in vitro evaluation of the effect of viable cells and high molecular weight potential postbiotics on Helicobacter pylori 184
Development of hybrid materials based on hydroxyethylmethacrylate as supports for improving cell adhesion and proliferation 183
4. Nuovi materiali per la produzione di canali di dentina artificiale per la valutazione della strumentazione endodontica e l’esercitazione clinica endodontica 183
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 182
Gelatin-biofermentative unsulfated glycosaminoglycans semi-interpenetrating hydrogels via microbial-transglutaminase crosslinking enhance osteogenic potential of dental pulp stem cells 182
Human Ng2+ adipose stem cells loaded in vivo on a new crosslinked hyaluronic acid-Lys scaffold fabricate a skeletal muscle tissue. 181
Cytoskeleton Modifications and Autophagy Induction in TCam-2 Seminoma Cells Exposed to Simulated Microgravity 181
A novel injectable poly(ε-caprolactone)/calcium sulfate system for bone regeneration: Synthesis and characterization 180
A complete hyaluronan hydrodynamic characterization using a triple detector-SEC system during in vitro enzymatic degradation 180
Hybrid Complexes of High and Low Molecular Weight Hyaluronans Highly Enhance HASCs Differentiation: Implication for Facial Bioremodelling 178
In vitro analysis of the effects on wound healing of high- and low-molecular weight chains of hyaluronan and their hybrid H-HA/L-HA complexes 177
Production of succinic acid from Basfia succiniciproducens up to the pilot scale from Arundo donax hydrolysate 177
Hard-to-heal wound treated with Integra Flowable Wound Matrix: Analysis and clinical observations 176
A combined fermentative-chemical approach for the scalable production of pure E. coli monophosphoryl lipid A. 174
Beta-Defensin-2 and Beta-Defensin-3 Reduce Intestinal Damage Caused by Salmonella typhimurium Modulating the Expression of Cytokines and Enhancing the Probiotic Activity of Enterococcus faecium 174
Lactobacillus plantarum: microfiltration experiments for the production of probiotic biomass to be used in food and nutraceutical preparations. 173
Biotechnological transformation of hydrocortisone to 16α-hydroxy hydrocortisone by Streptomyces roseochromogenes 171
Comparative analysis of commercial dermal fillers based on crosslinked hyaluronan: physical characterization and in vitro enzymatic degradation 171
A multi-analytical approach to better assess the keratan sulfate contamination in animal origin chondroitin sulfate 171
Chemico-physical characterization of hybrid composites based on hydroxyethilmethacrylate and nanosilica 170
Advances in the 16α-hydroxy transformation of hydrocortisone by Streptomyces roseochromogenes 167
Lactobacillus brevis CD2: Fermentation Strategies and Extracellular Metabolites Characterization 166
Biotechnological Production and Application of Hyaluronan 164
Differential Secretome Profiling of Human Osteoarthritic Synoviocytes Treated with Biotechnological Unsulfated and Marine Sulfated Chondroitins 164
Optical monitoring of cell migration processes in a 3D scaffold 163
European chondroitin sulfate and glucosamine food supplements: a systematic quality and quantity assessment compared to pharmaceuticals 163
Hyaluronan-Based Gel Promotes Human Dental Pulp Stem Cells Bone Differentiation by Activating YAP/TAZ Pathway. 163
Complete Lipooligosaccharide Structure from Pseudoalteromonas nigrifaciens Sq02-Rifr and Study of Its Immunomodulatory Activity 163
No Waste from Waste: Membrane-Based Fractionation of Second Cheese Whey for Potential Nutraceutical and Cosmeceutical Applications, and as Renewable Substrate for Fermentation Processes Development 162
Enhanced Streptomyces roseochromogenes melanin production by using the marine renewable source Posidonia oceanica egagropili 162
Concentrated buffalo whey as substrate for probiotic cultures and as source of bioactive ingredients: A local circular economy approach towards reuse of wastewaters 162
Antioxidants positively regulate obesity dependent circRNAs - sperm quality - functional axis 161
An in vitro study to assess the effect of hyaluronan-based gels on muscle-derived cells: Highlighting a new perspective in regenerative medicine 161
Hybrid complexes of high and low molecular weight: evaluation using an in vitro model of osteoarthritis. 160
Application of a 22L scale membrane bioreactor and cross-flow ultrafiltration to obtain purified chondroitin. 159
Chondroitin purification from fermentation broth through membrane processes. 159
Production and purification of higher molecular weight chondroitin by metabolically engineered Escherichia coli K4 strains 159
Hyaluronan and Derivatives: An In Vitro Multilevel Assessment of Their Potential in Viscosupplementation 159
An enzymatic process for the production of the pharmacologically active glycoside desglucodesrhamnoruscin from ruscus aculeatus L. 158
Highly Concentrated Stabilized Hybrid Complexes of Hyaluronic Acid: Rheological and Biological Assessment of Compatibility with Adipose Tissue and Derived Stromal Cells towards Regenerative Medicine 157
Engineering a branch of the UDP-precursor biosynthesis pathway enhances the production of capsular polysaccharide in Escherichia coli O5:K4:H4. 157
Engineering S. equi subsp. zooepidemicus towards concurrent production of hyaluronic acid and chondroitin biopolymers of biomedical interest 156
A biophysically-defined hyaluronic acid-based compound accelerates migration and stimulates the production of keratinocyte-derived neuromodulators 156
< i> Saccharomyces pastorianus as cell factory to improve glutathione production using novel fermentation strategies 155
A microbiological-chemical strategy to produce chondroitin sulfate a, c 155
Comparative Analyses of Pharmaceuticals or Food Supplements Containing Chondroitin Sulfate: Are Their Bioactivities Equivalent? 155
A microfiltration bioreactor to achieve high cell density in Sulfolobus solfataricus fermentation 154
A novel bioprocess for L(-)- Carnitine Production Exploiting Immobilized Proteus Mirabilis in Poly(vinylalcohol) cryogels 152
PROCESS FOR OBTAINING HYALURONIC ACID OF DEFINED MOLECULAR WEIGHT 152
Molecular weight determination of heparosan- and chondroitin-like capsular polysaccharides: figuring out differences between wild -type and engineered Escherichia coli strains 151
Hybryd Cooperative complexes of Hyaluronic acid 151
A Semisynthetic Approach to New Immunoadjuvant Candidates: Site-Selective Chemical Manipulation of Escherichia coli Monophosphoryl Lipid A 151
Chondroitin sulfate in usa dietary supplements in comparison to pharma grade products: Analytical fingerprint and potential anti‐inflammatory effect on human osteoartritic chondrocytes and synoviocytes 151
Cellulose from Posidonia oceanica Sea Balls (Egagropili) as Substrate to Enhance Streptomyces roseochromogenes Cellulase Biosynthesis 150
Production of capsular polysaccharide from Escherichia coli K4 for biotechnological applications 150
Hyaluronan Hybrid Cooperative Complexes as a Novel Frontier for Cellular Bioprocesses Re-Activation. 150
Antioxidant and Hypolipidemic Activity of Açai Fruit Makes It a Valuable Functional Food 149
Molecular Fingerprint of Human Pathological Synoviocytes in Response to Extractive Sulfated and Biofermentative Unsulfated Chondroitins 148
PROCESSO PER LA PRODUZIONE DI TREALOSIO DA DESTRINE AD ALTE TEMPERATURE 148
Biotechnological production of chondroitin. 148
Production of human pro-relaxin H2 in the yeast Pichia pastoris 148
Capsular polysaccharide from a fish-gut bacterium induces/promotes apoptosis of colon cancer cells in vitro through Caspases' pathway activation 148
Evaluation of a high temperature immobilised enzyme reactor for production of non-reducing oligosaccharides 147
Hyaluronan hydrogels with a low degree of modification as scaffolds for cartilage engineering 147
Ectoine from halophilic microorganisms induces the expression of hsp70 and hsp70B' in human keratinocytes modulating the proinflammatory response 146
Produzione biotecnologica di condroitina 146
A comprehensive in vitro characterization of non-crosslinked, diverse tissue-derived collagen-based membranes intended for assisting bone regeneration 146
Improved production of succinic acid from Basfia succiniciproducens growing on A-donax and process evaluation through material flow analysis 145
Development of novel composite based on biocompatibile matrix and functionalised fumed silica 144
Design of inhibitors of influenza virus membrane fusion: Synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series. 144
Physiological characterization and quantitative proteomic analyses of metabolically engineered E. coli K4 strains with improved pathways for capsular polysaccharide biosynthesis 144
S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a 144
Polydatin Incorporated in Polycaprolactone Nanofibers Improves Osteogenic Differentiation 143
Hyaluronan dermal fillers via crosslinking with 1,4-butandiol diglycidyl ether: Exploitation of heterogeneous reaction conditions. 143
A novel polycaprolactone/calcium sulphate system for bone regeneration 143
Valorization of olive mill wastewater by membrane processes to recover natural antioxidant compounds for cosmeceutical and nutraceutical applications or functional foods 143
Decellularized Human Dermal Matrix as a Biological Scaffold for Cardiac Repair and Regeneration 143
Chondroitin sulfate: are the purity and the structural features well assessed? A review on the analytical challenges 142
A Novel approach in biotransformation exploiting extremophilic biocatalysts 142
Is molecular size a discriminating factor in hyaluronan interaction with human cells? 142
Protective effect of extractive and biotechnological chondroitin in insulin amyloid and advanced glycation end product-induced toxicity 141
Correction: Vassallo et al. Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins. Pharmaceuticals 2023, 16, 1429 140
Ectoine from halophilic microorganisms induce the expression of hsp70 and hsp70' in human keratinocytes modulating the proinflammatory response 140
Dairy liquid waste as substrate to obtain biotechnological chondroitin: A circular economy approach 139
Potential of Biofermentative Unsulfated Chondroitin and Hyaluronic Acid in Dermal Repair 139
Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase 137
Unsulfated biotechnological chondroitin by itself as well as in combination with high molecular weight hyaluronan improves the inflammation profile in osteoarthritis in vitro model 136
Bifidobacterium animalis subsp. lactis HN019 live probiotics and postbiotics: production strategies and bioactivity evaluation for potential therapeutic properties 135
Encapsulation of calcium sulphate hemi-hydrate(plaster of Paris)in crosslinked polycaprolactone 135
Molecular Mechanisms at the Basis of Pharmaceutical Grade Triticum vulgare Extract Efficacy in Prompting Keratinocytes Healing. 135
The Potential Benefits of a Novel Food Supplement Based on Cannabis Sativa, Boswellia, and Fish Oil for Pain and Inflammation in Physical Activity: Unraveling the Role of Orexin-A Modulation 134
Totale 16.182
Categoria #
all - tutte 119.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.468 0 0 35 36 516 19 25 54 57 142 121 463
2022/20233.755 280 69 80 338 469 307 13 240 1.795 30 60 74
2023/20241.265 108 49 62 75 391 144 32 47 22 21 130 184
2024/20254.245 70 38 41 126 737 587 610 371 576 493 341 255
2025/202618.931 736 645 912 848 1.580 10.592 991 935 718 432 313 229
2026/20271.154 143 605 406 0 0 0 0 0 0 0 0 0
Totale 35.864